New research has found that GLP-1 drugs may affect the interpretation of oncological FDG PET-CT scans, leading to unnecessary tests. They observed several atypical patterns of tracer uptake that could be misinterpreted as pathology if a patient’s medication history is not considered.
Seeking commentary, including:
What should doctors be aware of as they provide treatment?
posted10/9/2025
deadline10/13/2025
processing
published10/17/2025
Recently published by Healthgrades
Psychiatrist: Genetic differences in how women/men experience depression
Important genetic differences in how females and males experience depression have been revealed for the first time in findings that could pave the way for more targeted interventions and treatments.
In the study, published in Nature Communications, scientists found that genetic factors contribute more to depression risk in females than in males. The team discovered about twice as many genetic "flags" for depression in the DNA of females as they did in that of males.
Seeking commentary, including:
What should doctors consider about these differences when treating women versus men?